You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

OXILAN-300 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Oxilan-300, and when can generic versions of Oxilan-300 launch?

Oxilan-300 is a drug marketed by Guerbet and is included in one NDA.

The generic ingredient in OXILAN-300 is ioxilan. There is one drug master file entry for this compound. Additional details are available on the ioxilan profile page.

Summary for OXILAN-300
US Patents:0
Applicants:1
NDAs:1
Raw Ingredient (Bulk) Api Vendors: 48
Patent Applications: 1,502
DailyMed Link:OXILAN-300 at DailyMed
Drug patent expirations by year for OXILAN-300

US Patents and Regulatory Information for OXILAN-300

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Guerbet OXILAN-300 ioxilan INJECTABLE;INJECTION 020316-001 Dec 21, 1995 DISCN No No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for OXILAN-300

See the table below for patents covering OXILAN-300 around the world.

Country Patent Number Title Estimated Expiration
European Patent Office 0233249 MILIEUX DE CONSTRASTE NON-IONIQUES A BASE DE POLYOL OBTENUS A PARTIR DE MILIEUX DE CONTRASTE IONIQUES. (NON-IONIC POLYOL CONTRAST MEDIA FROM IONIC CONTRAST MEDIA.) ⤷  Try a Trial
Japan H0813794 ⤷  Try a Trial
Denmark 174745 ⤷  Try a Trial
Germany 3689330 ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.